Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. COHR

Go back to Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
(NASDAQ: ADAG) Delayed: 3.21 -0.1 (3.02%)
Previous Close $3.31    52 Week High $ 
Open $3.34    52 Week Low $ 
Day High $3.35    P/E N/A 
Day Low $3.18    EPS $ 
Volume 97,782